NCT03716271

Brief Summary

Clinical assessment of a new optical element for presbyopia compensation - the Light Sword Lens.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 23, 2018

Completed
Last Updated

October 23, 2018

Status Verified

October 1, 2018

Enrollment Period

1 year

First QC Date

October 10, 2018

Last Update Submit

October 22, 2018

Conditions

Keywords

presbyopia compensationEDFLight Sword Lens

Outcome Measures

Primary Outcomes (2)

  • Visual Acuity based on The Early Treatment Diabetic Retinopathy Study protocol

    Examination for visual performance in 3 trials: reference (with lens for distance correction); stenopeic (distance correction with a pinhole ϕ=1,25 mm) and Light Sword Lens (distance correction with a Light Sword Lens). In each trial, visual acuity assessment in 7 tasks for defocus from 0.2D to 3.0D. The degree of homogeneity through defocus was determined. Reference and stenopeic trials were compared to Light Sword Lens results. Statistical analysis: Friedman analysis of variance, Nemenyi post-hoc, Wilcoxon tests , p-value \< 0.05 is considered significant.

    day one

  • Contrast sensitivity based on Pelli-Robson method

    Contrast sensitivity assessment in 2 tasks for defocus 0.3D and 2.5D The degree of homogeneity through defocus was determined. Reference and stenopeic trials were compared to Light Sword Lens results. Statistical analysis: Friedman analysis of variance, Nemenyi post-hoc, Wilcoxon tests , p-value \< 0.05 is considered significant.

    day one

Interventions

Visual Acuity Examination with a novel lens set in an ophthalmic trial frame

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • emmetropic or hyperopic eyes with a spherical error of maximum +1.75D and astigmatism of ≤ 0.5D.
  • Corrected distance visual acuity (CDVA) had to be better than 0.1 logMAR (20/25) and at the same time contrast sensitivity (CS) could not be less than 1.9 logCS. -Uncorrected near visual acuity was required to be worse than 0.4 logMAR (20/50), as a proof of presbyopia.

You may not qualify if:

  • any history of ophthalmic surgeries
  • evidence of serious ocular or brain pathologies affecting visual acuity (VA)
  • clinically active inflammation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Kakarenko K, Ducin I, Grabowiecki K, Jaroszewicz Z, Kolodziejczyk A, Mira-Agudelo A, Petelczyc K, Skladowska A, Sypek M. Assessment of imaging with extended depth-of-field by means of the light sword lens in terms of visual acuity scale. Biomed Opt Express. 2015 Apr 16;6(5):1738-48. doi: 10.1364/BOE.6.001738. eCollection 2015 May 1.

    PMID: 26137376BACKGROUND
  • Mira-Agudelo A, Torres-Sepulveda W, Barrera JF, Henao R, Blocki N, Petelczyc K, Kolodziejczyk A. Compensation of Presbyopia With the Light Sword Lens. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6870-6877. doi: 10.1167/iovs.16-19409.

    PMID: 28002561BACKGROUND

MeSH Terms

Conditions

Presbyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Krzysztof Petelczyc, PhD

    Warsaw University of Technology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 10, 2018

First Posted

October 23, 2018

Study Start

April 1, 2016

Primary Completion

April 1, 2017

Study Completion

February 1, 2018

Last Updated

October 23, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will share

data will be supplemented to published outcomes

Shared Documents
STUDY PROTOCOL
Time Frame
data will be supplemented to published outcomes